Evoke Pharma
EVOK
EVOK
8 hedge funds and large institutions have $966K invested in Evoke Pharma in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 1 reducing their positions, and 4 closing their positions.
Holders
8
Holders Change
-3
Holders Change %
-27.27%
% of All Funds
0.11%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
2
Reduced
1
Closed
4
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
NCM
1
Nantahala Capital Management
New Canaan,
Connecticut
|
$655K |
| 2 |
2
UBS Group
Zurich,
Switzerland
|
$5.56K |
| 3 |
SS
3
SBI Securities
Tokyo,
Japan
|
$332 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
NCM
1
Nantahala Capital Management
New Canaan,
Connecticut
| $655K | 148,194 | +91,945 | +163% |
|
|
BL
2
Bleichroeder LP
New York
| $304K | 68,750 | – | – |
|
|
3
UBS Group
Zurich,
Switzerland
| $5.56K | 1,258 | +1,168 | +1,298% |
|
4
BlackRock
New York
| $539 | 122 | – | – |
|
|
SS
5
SBI Securities
Tokyo,
Japan
| $332 | 75 | +75 | New |
|
6
Morgan Stanley
New York
| $137 | 31 | – | – |
|
|
NA
7
NewEdge Advisors
New Orleans,
Louisiana
| $75 | 17 | – | – |
|
8
Bank of America
Charlotte,
North Carolina
| $40 | 9 | -16 | -64% |
|
|
ACM
9
AIGH Capital Management
Baltimore,
Maryland
| – | – | -70,546 | Closed |
|
|
CCM
10
Corsair Capital Management
New York
| – | – | -11,667 | Closed |
|
|
TRCT
11
Tower Research Capital (TRC)
New York
| – | – | -816 | Closed |
|
12
Citigroup
New York
| – | – | -4 | Closed |
|
|
CFGS
13
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|